Top Markets
Coin of the day
Aeglea BioTherapeutics, Inc. Aeglea BioTherapeutics, Inc.

Aeglea BioTherapeutics, Inc.

AGLE
Hisse Senetlerindeki Sıralama #23495
Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated... Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating human enzyme therapies for rare metabolic diseases. Their leading candidate, pegzilarginase, a recombinant human Arginase 1, is currently in the pivotal Phase III PEACE trial to assess its safety and effectiveness for treating Arginase 1 deficiency. Furthermore, the company is developing AGLE-177, a polyethylene glycol modified enzyme, which is progressing through Phase I/II clinical trials for homocystinuria. Their early-stage pipeline includes AGLE-325 for cystinuria, along with other ongoing research initiatives. Founded in 2013, the company was initially known as Aeglea BioTherapeutics Holdings, LLC, changing its name to Aeglea BioTherapeutics, Inc. in March 2015. It is based in Austin, Texas.
Hisse Fiyatı
$19.30
Son senkronizasyon: 2023-12-26
Piyasa Değeri
$72.77M
Değişim (1 gün)
6.22%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Aeglea BioTherapeutics, Inc. (AGLE)

Kategori

Aeglea BioTherapeutics, Inc. (AGLE) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $17.81 - 2023-12-01

Gün sonu en düşük fiyat: $240.00 - 2016-04-01
Aeglea BioTherapeutics, Inc. için hisse fiyatı geçmişi: 2016 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2023 80.43%
2022 -90.79%
2021 -48.55%
2020 6.06%
2019 3.25%
2018 49.19%
2017 -3.90%
2016 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH